Table 1.
Patient characteristics (n = 30)
| Patient characteristics | |
|---|---|
| Age, years | |
| Range | 25–65 |
| Sex, N (%) | |
| Male | 20 (66.7) |
| Female | 10 (33.3) |
| Ethnicity, N (%) | |
| Hispanic or Latino | 3 (10.0) |
| Black or African American | 2 (6.7) |
| White | 25 (83.3) |
| Geographic region, N (%) | |
| California | 28 (93.3) |
| Michigan | 1 (3.3) |
| Arizona | 1 (3.3) |
| HCV genotype, N (%) | |
| 1 (a/b) | 18 (60.0) |
| 2 (a/b) | 2 (6.7) |
| 3 (a/b) | 5 (16.7) |
| Unknown | 5 (16.7) |
| Baseline viral load, IU/mLa | 1.0 × 105 − 6.9 × 107 (8.3 × 106 ± 1.2 × 107) |
| Baseline AST, U/La | 20−243 (67.7±46.6) |
| Baseline ALT, U/La | 24−276 (91.9±58.4) |
| Baseline Fib-4b | 0.38−4.15 (1.90) |
Baseline viral load, AST, and ALT values presented as range (Mean ± SD). Fib-4 value presented as range (median).
AST: aspartate transaminase, ALT: alanine transaminase, N: sample size, HCV: hepatitis C virus, lU/mL: international units per milliliter, U/L: units per liter.
a
Baseline viral load, AST, and ALT values presented as range (mean ± SD).
b
Baseline Fib-4 value presented as range (median).